Lift Mobile Mindfulness for COVID-19 Distress Symptoms
(LIFTCOVID Trial)

Recruiting in Palo Alto (17 mi)

+3 other locations

Overseen byChristopher E Cox, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Duke University

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a randomized clinical trial (RCT) nested within the NIH PETAL Network's COVID cohort study (BLUE CORAL \[Biology and Longitudinal Epidemiology: COVID Observational Study\]) of patients hospitalized for COVID-19-related illness. COVID-19 patients enrolled in BLUE CORAL with elevated distress symptoms 1 month post-discharge will be randomized to either the Lift mobile app intervention or a usual care control.

Research Team

Christopher E Cox, MD

Principal Investigator

Duke University

Eligibility Criteria

Inclusion Criteria

BLUE CORAL eligibility (the parent cohort study from which RCT participants will be recruited)

Adult hospitalized within 14 days of a positive PCR test for COVID-19

Evidence of acute COVID-19, with fever or respiratory manifestations, as characterized by signs and symptoms such as cough, dyspnea, tachypnea, hypoxemia, and infiltrates on chest imaging.

Treatment Details

Interventions

Lift (Behavioral Intervention)

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Lift mobile mindfulness programExperimental Treatment1 Intervention

Will receive standard dose Lift mobile mindfulness program intervention content, app-based response to elevated symptoms, and no introductory call from a therapist. This program lasts 1 month and includes 4 unique weeks' worth of audio, video, and text content.

Group II: Usual care controlActive Control1 Intervention

Usual care.